SCHEMBL21937271

SCHEMBL21937271

C=CCC1C2CCC(N)CCC1CC2

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.33
NOS1 P29475 2/20 0.33
NOS2 P35228 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14954535 0.87 NOS1 (0.30) NOS3NOS1NOS2
SCHEMBL9875849 0.81 NOS3 (0.33) NOS3NOS1NOS2
SCHEMBL21474503 0.79 NOS3 (0.36) NOS3NOS1NOS2
SCHEMBL1242056 0.75 NOS1 (0.39) NOS3NOS1NOS2
SCHEMBL4791379 0.75 NOS1 (0.39) NOS3NOS1NOS2
SCHEMBL1242058 0.75 NOS1 (0.39) NOS3NOS1NOS2
SCHEMBL10016260 0.70 ALDH1A1 (0.31)
SCHEMBL19204651 0.67
SCHEMBL21936203 0.67
SCHEMBL2154540 0.66 ALDH1A1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 EP disclosed